{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:29:34Z","timestamp":1772753374700,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s00108-023-01478-1","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T07:02:51Z","timestamp":1673852571000},"page":"25-33","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Symptomlinderung bei fortgeschrittener Krebserkrankung","Symptom management in advanced cancer"],"prefix":"10.1007","volume":"64","author":[{"given":"Friedemann","family":"Nauck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gesine","family":"Benze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,16]]},"reference":[{"key":"1478_CR1","unstructured":"Arzneimittelkommission der Deutschen \u00c4rzteschaft (2007) Empfehlung zur Therapie von Tumorschmerzen. Arzneiverordn Prax 34(Sonderheft 1)"},{"key":"1478_CR2","unstructured":"AWMF (2020) https:\/\/www.awmf.org\/fileadmin\/user_upload\/Leitlinien\/145_Schmerzgesellschaft\/145-003pw8_S3_LONTS_2020-04.pdf. Zugegriffen: 1. Aug. 2022"},{"key":"1478_CR3","volume-title":"Textbook of pain","year":"1985","unstructured":"Bonica\u00a0JJ, Wall\u00a0PD, Melzack\u00a0R (Hrsg) (1985) Textbook of pain. Livingstone, Edinburgh"},{"key":"1478_CR4","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","volume":"13","author":"A Caraceni","year":"2012","unstructured":"Caraceni\u00a0A, Hanks\u00a0G, Kaasa\u00a0S, Bennett\u00a0MI, Brunelli\u00a0C, Cherny\u00a0N, Dale\u00a0O, De Conno\u00a0F, Fallon\u00a0M, Hanna\u00a0M, Haugen\u00a0DF, Juhl\u00a0G, King\u00a0S, Klepstad\u00a0P, Laugsand\u00a0EA, Maltoni\u00a0M, Mercadante\u00a0S, Nabal\u00a0M, Pigni\u00a0A, Radbruch\u00a0L, Reid\u00a0C, Sjogren\u00a0P, Stone\u00a0PC, Tassinari\u00a0D, Zeppetella\u00a0G, European Palliative Care Research Collaborative (EPCRC), European Association for Palliative Care (EAPC) (2012) Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 13:e58\u2013e68","journal-title":"Lancet Oncol"},{"key":"1478_CR5","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/ajhp\/53.16.1917","volume":"53","author":"KM Diener","year":"1996","unstructured":"Diener\u00a0KM (1996) Bisphosphonates for controlling pain from metastatic bone disease. Am J Health Syst Pharm 53:1917\u20131927","journal-title":"Am J Health Syst Pharm"},{"key":"1478_CR6","unstructured":"(2017) Leitlinie Supportive Therapie: Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft \u2013 Deutsche Krebshilfe \u2013 AWMF). Supportive Therapie bei onkologischen PatientInnen \u2013 Langversion 1.1, 2017, AWMF Registernummer: 032\/054OL. http:\/\/leitlinienprogramm-onkologie.de\/Supportive-Therapie.95.0.html. Zugegriffen: 1. Aug. 2022"},{"key":"1478_CR7","first-page":"459","volume-title":"Oxford textbook of palliative medicine","author":"KA Mannix","year":"2004","unstructured":"Mannix\u00a0KA (2004) Palliation of nausea and vomiting. In: Doyle\u00a0D et\u00a0al (Hrsg) Oxford textbook of palliative medicine. Oxford University Press, Oxford, S\u00a0459\u2013468"},{"key":"1478_CR8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrc747","volume":"2","author":"PW Mantyh","year":"2002","unstructured":"Mantyh\u00a0PW, Clohisy\u00a0DR, Koltzenburg\u00a0M, Hunt\u00a0SP (2002) Molecular mechanisms of cancer pain. Nat Rev Cancer 2:201\u2013209","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"1478_CR9","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00120-009-2038-9","volume":"48","author":"F Nauck","year":"2009","unstructured":"Nauck\u00a0F (2009) Tumorschmerztherapie. Urologe 48(10):1175\u20131181","journal-title":"Urologe"},{"key":"1478_CR10","unstructured":"S3-Leitlinie Komplement\u00e4rmedizin. https:\/\/www.leitlinienprogramm-onkologie.de\/fileadmin\/user_upload\/Downloads\/Leitlinien\/Komplement%C3%A4r\/Version_1\/LL_Komplement%C3%A4r_Langversion_1.0.pdf. Zugegriffen: 1. Aug. 2022"},{"key":"1478_CR11","unstructured":"S3-Leitlinie Palliativmedizin. https:\/\/www.leitlinienprogramm-onkologie.de\/fileadmin\/user_upload\/Downloads\/Leitlinien\/Palliativmedizin\/Version_2\/LL_Palliativmedizin_Langversion_2.2.pdf. Zugegriffen: 1. Aug. 2022"},{"issue":"9","key":"1478_CR12","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1177\/014107680109400904","volume":"94","author":"C Saunders","year":"2001","unstructured":"Saunders\u00a0C (2001) The evolution of palliative care. J\u00a0R Soc Med 94(9):430\u2013432","journal-title":"J R Soc Med"},{"key":"1478_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ejpain.2004.06.001","volume":"9","author":"KB Svendsen","year":"2005","unstructured":"Svendsen\u00a0KB, Andersen\u00a0S, Arnason\u00a0S et al (2005) Breakthrough pain in malignant and non-malignant diseases: a\u00a0review of prevalence, characteristics and mechanisms. Eur J Pain 9:195\u2013206","journal-title":"Eur J Pain"},{"key":"1478_CR14","unstructured":"World Health Organisation (WHO) (1986) Cancer pain relief. WHO, Geneva. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/43944\/9241561009_eng.pdf. Zugegriffen: 1. Aug. 2022"},{"key":"1478_CR15","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/S0140-6736(02)11489-9","volume":"360","author":"JE Edwards","year":"2002","unstructured":"Edwards\u00a0JE, McQuay\u00a0HJ (2002) Dipyrone and agranulocytosis: what is the risk? Lancet 360:1438","journal-title":"Lancet"},{"key":"1478_CR16","volume-title":"Arzneimitteltherapie in der Palliativmedizin","year":"2018","unstructured":"R\u00e9mi\u00a0C, Bausewein\u00a0C, Charlesworth\u00a0S, Wilcock\u00a0A, Howard\u00a0P (Hrsg) (2018) Arzneimitteltherapie in der Palliativmedizin. Urban & Fischer, M\u00fcnchen"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-023-01478-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-023-01478-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-023-01478-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T17:06:18Z","timestamp":1674147978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-023-01478-1"}},"subtitle":["Linderung von Schmerzen, \u00dcbelkeit und Erbrechen im palliativen Kontext","Relief of pain, nausea and vomiting in the context of palliative care"],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["1478"],"URL":"https:\/\/doi.org\/10.1007\/s00108-023-01478-1","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"16 January 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F.\u00a0Nauck und G.\u00a0Benze geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}